Pane wikiwiki
He alakaʻi polokalamu peptide ʻoe e hoʻoholo ana i ka mea e hana ai me kāu papahana i kēia hapaha, a ua huikau maoli ke kiʻi hoʻomalu i mua ou. ʻO ka Senate HE…
He aha ka mea i hoʻololi maoli ma FDA i 2026, a he aha ka mea i koho wale ʻia?
Mea hoʻolako ʻike peptide ʻO Peptides Co ʻAʻole hoʻololi ka hālāwai hoʻolohe manaʻo i ka ʻae ʻana i ka peptide, ka hoʻohuihui ʻana a i ʻole nā koi o ka maikaʻi. E loiloi i nā hana i hoʻopuka ʻia: Iulai 2026 ʻO nā loiloi alakaʻi peptide a me ka loiloi kulekele ʻOkakopa i kā lākou kūlana a me ka laulā. ʻAʻole pono ke kūkākūkā alakaʻi e pani i kēlā loiloi kikoʻī huahana.

ʻO ka nīnau aʻoaʻo-komite kahi i hui ai ka loiloi peptide komite aʻoaʻo FDA i ka hoʻololi alakaʻi.. Ua koi aku nā senatoa iā Overton e hoʻohiki i ka hoʻoikaika ʻana i nā komite aʻoaʻo FDA a ʻimi i nā hōʻoia e mālama nā komite i kā lākou kuleana., e pili ana i ke kua o ka roughly 50 nā komite aʻoaʻo ʻepekema a ʻenehana a me nā panela e ʻākoakoa pinepine nei (hōʻike ʻana i ka hoʻolohe manaʻo, C&IN, 2026). Kaawale, Hōʻike ka hōʻike i kahi hoʻoponopono hou o ka papa inoa PCAC ma mua o ka hālāwai Iulai, me nā lālā i hoʻohui ʻia nā pilina peptide-industry (hōʻike ʻia nā loli o ka papa inoa ma mua o ke koho balota, Pharmaforum, 2026). He kumu hoʻokahi kēlā moʻokāki a ʻaʻohe helu lālā, no laila e mālama ʻia e like me ka mea i hōʻike ʻia ma mua o ka hoʻokumu ʻia.
|
Hōʻoiaʻiʻo kaʻina hana |
Hāmama mau |
|---|---|
|
Ua mālama ʻia ka hoʻolohe manaʻo koho 24 Kepakemapa 2026 |
ʻAʻohe koho komite; ʻaʻole i hoʻolaha ʻia ke koho papahele |
|
Luna komisina ma kahi, ʻaʻole i hōʻoia ʻia e ka Senate |
ina paha, a i ka manawa hea, he komisina i hoʻopaʻa ʻia i ka ʻoihana |
|
Ua hui ʻo PCAC i ka lā 23–24 Iulai 2026 a koho |
He aha ka FDA e hana ai me nā ʻōlelo paipai |
|
Ua hele kekahi kulekele komo manawa i OMB ma 14 ʻOkakopa 2026 |
He pilikia paha, ma ke ano hea, a hoʻihoʻi ʻia paha |
He aha ka mea a ka peptide advisory panel i koho ai, a he aha ka hana ma ke kānāwai?
ʻO Iulai 2026 koho balota, ʻaʻohe mea ʻē aʻe. ʻO ka wehewehe ponoʻī a FDA e pili ana i ka hana ʻana o nā komite ʻōlelo aʻoaʻo e ʻōlelo ʻo "ʻo ia wale nō, ʻōlelo aʻo, a mai hoopaa i ka oihana i kekahi olelo hooholo,” me ka hoʻoholo hoʻoholo hoʻoholo hope e waiho ʻia me ka ʻoihana (ʻO ka wehewehe ponoʻī a FDA e pili ana i ka hana ʻana o nā komite aʻoaʻo, kēia manawa 2026). ʻO ka ʻōlelo hoʻohui ʻōlelo a ke kōmike ma ka Federal Register e hoʻonohonoho i kāna hana ma ke ʻano he ʻōlelo paipai kūpono i ke Komisina no ka hui ʻana ma lalo o nā pauku 503A a me 503B (ka ʻōlelo palapala a ke kōmike ma ka Federal Register, 2015).

<papa helu ="blog-chart" kaila="laula-nui:640px;palena palena:1.5rem auto;nui-momona:12px;kiʻekiʻe laina:1.3;kala kala:hooilina"> <svg viewBox="0 0 560 380" kaila="laula-nui: 100%; kiekie: kaʻa; font-ohana: 'Inter', ʻōnaehana-ui, sans-serif; kala kala: #1e293b; --pakuhi-muted: #64748b;" kuleana="img" aria-labelledby="pcac-peptide-votes-iulai-2026-title pcac-peptide-votes-iulai-2026-desc"> <kaila> /* Hoʻokomo ka mea hāʻawi i ka pakuhi i loko o kahi iframe nona ka ʻeleʻele ʻeleʻele, a he ʻano ʻokoʻa ka iframe i ka pakuhi, no laila ua hōʻike ʻia nā pahu pahu leka me he mau papa ʻeleʻele a puni (prod 09-22). Akaka ka palapala i loko o ka iframe ma ka paʻamau; ʻO ka pena kiʻi ma ʻaneʻi e uhi ana i ke kāʻei o ka element, a ke kau ʻia ka pakuhi, ʻaʻohe mea pili kēia. E mālama i nā pale kihi ma waho o kēia poloka: ʻO kahi mea ʻano i loko o kahi SVG i hoʻokaʻawale ʻia ma ke ʻano he ʻike haole, no laila, hoʻolei kekahi bracket hele i kēlā me kēia lula i loko. */ html, kino { hope: #ffffff; palena palena: 0; } @media (makemake-hoemi-holo: hoemi) { * { hoʻouluulu: ʻaʻohe !mea nui; hoʻololi: ʻaʻohe !mea nui; } } </kaila> <pololei x="0" y="0" laula="560" kiekie="380" rx="8" hoʻopiha="#ffffff" /> <inoa id="pcac-peptide-votes-iulai-2026-title">Nā koho peptide PCAC, Iulai 2026</inoa> <wehewehe id="pcac-peptide-votes-iulai-2026-desc">Nā koho peptide PCAC, Iulai, e like me ka manao mai ke kumu i oleloia. Nā koho peptide PCAC, Iulai 2026. ʻikepili pā hui: BPC-157: ʻAe 8, ʻAʻole 6, E hoole 1; KPV: ʻAe 8, ʻAʻole 6, E hoole 1; TB-500: ʻAe 8, ʻAʻole 6, E hoole 1; c-HUAOLELO: ʻAe 7, ʻAʻole 5, E hoole 2; Mai hoʻolohe: ʻAe 8, ʻAʻole 5, E hoole 1; Epitalona: ʻAe 7, ʻAʻole 4, E hoole 1; Emideltide/DSIP: ʻAe 6, ʻAʻole 7, E hoopau i ka 1. Source: McDermott Will & Emery, PCAC recap 2026-07-28.</wehewehe> <kikokikona x="280.0" y="29" heleuma kikokikona="waena" font-size="18" font-kaumaha="800" hoʻopiha="kala kala">Nā koho peptide PCAC, Iulai 2026</kikokikona> <laina x1="72" y1="277.0" x2="492" y2="277.0" hahau ="kala kala" opacity="0.08" /> <laina x1="72" y1="230.8" x2="492" y2="230.8" hahau ="kala kala" opacity="0.08" /> <laina x1="72" y1="184.5" x2="492" y2="184.5" hahau ="kala kala" opacity="0.08" /> <laina x1="72" y1="138.2" x2="492" y2="138.2" hahau ="kala kala" opacity="0.08" /> <laina x1="72" y1="92.0" x2="492" y2="92.0" hahau ="kala kala" opacity="0.08" /> <kikokikona x="66" y="281.0" heleuma kikokikona="hopena" font-size="10" hoʻopiha="kala kala" opacity="0.7">0</kikokikona> <kikokikona x="66" y="234.8" heleuma kikokikona="hopena" font-size="10" hoʻopiha="kala kala" opacity="0.7">2.5</kikokikona> <kikokikona x="66" y="188.5" heleuma kikokikona="hopena" font-size="10" hoʻopiha="kala kala" opacity="0.7">5</kikokikona> <kikokikona x="66" y="142.2" heleuma kikokikona="hopena" font-size="10" hoʻopiha="kala kala" opacity="0.7">7.5</kikokikona> <kikokikona x="66" y="96.0" heleuma kikokikona="hopena" font-size="10" hoʻopiha="kala kala" opacity="0.7">10</kikokikona> <pololei x="72.0" y="62" laula="10" kiekie="10" hoʻopiha="#f97316" /> <kikokikona x="87.0" y="71" font-size="11" hoʻopiha="kala kala">ʻAe</kikokikona> <pololei x="127.6" y="62" laula="10" kiekie="10" hoʻopiha="#38bdf8" /> <kikokikona x="142.6" y="71" font-size="11" hoʻopiha="kala kala">ʻAʻole</kikokikona> <pololei x="177.0" y="62" laula="10" kiekie="10" hoʻopiha="#a78bfa" /> <kikokikona x="192.0" y="71" font-size="11" hoʻopiha="kala kala">E hoole</kikokikona> <pololei x="79.0" y="129.0" laula="13.3" kiekie="148.0" hoʻopiha="#f97316" /> <kikokikona x="85.7" y="125.0" heleuma kikokikona="waena" font-size="9" hoʻopiha="kala kala">8</kikokikona> <pololei x="94.3" y="166.0" laula="13.3" kiekie="111.0" hoʻopiha="#38bdf8" /> <kikokikona x="101.0" y="162.0" heleuma kikokikona="waena" font-size="9" hoʻopiha="kala kala">6</kikokikona> <pololei x="109.7" y="258.5" laula="13.3" kiekie="18.5" hoʻopiha="#a78bfa" /> <kikokikona x="116.3" y="254.5" heleuma kikokikona="waena" font-size="9" hoʻopiha="kala kala">1</kikokikona> <kikokikona x="102.0" y="295.0" heleuma kikokikona="waena" font-size="10" hoʻopiha="kala kala" opacity="0.8"><puna x="102.0" dy="0">BPC-157</tspan></kikokikona> <pololei x="139.0" y="129.0" laula="13.3" kiekie="148.0" hoʻopiha="#f97316" /> <kikokikona x="145.7" y="125.0" heleuma kikokikona="waena" font-size="9" hoʻopiha="kala kala">8</kikokikona> <pololei x="154.3" y="166.0" laula="13.3" kiekie="111.0" hoʻopiha="#38bdf8" /> <kikokikona x="161.0" y="162.0" heleuma kikokikona="waena" font-size="9" hoʻopiha="kala kala">6</kikokikona> <pololei x="169.7" y="258.5" laula="13.3" kiekie="18.5" hoʻopiha="#a78bfa" /> <kikokikona x="176.3" y="254.5" heleuma kikokikona="waena" font-size="9" hoʻopiha="kala kala">1</kikokikona> <kikokikona x="162.0" y="295.0" heleuma kikokikona="waena" font-size="10" hoʻopiha="kala kala" opacity="0.8"><puna x="162.0" dy="0">KPV</tspan></kikokikona> <pololei x="199.0" y="129.0" laula="13.3" kiekie="148.0" hoʻopiha="#f97316" /> <kikokikona x="205.7" y="125.0" heleuma kikokikona="waena" font-size="9" hoʻopiha="kala kala">8</kikokikona> <pololei x="214.3" y="166.0" laula="13.3" kiekie="111.0" hoʻopiha="#38bdf8" /> <kikokikona x="221.0" y="162.0" heleuma kikokikona="waena" font-size="9" hoʻopiha="kala kala">6</kikokikona> <pololei x="229.7" y="258.5" laula="13.3" kiekie="18.5" hoʻopiha="#a78bfa" /> <kikokikona x="236.3" y="254.5" heleuma kikokikona="waena" font-size="9" hoʻopiha="kala kala">1</kikokikona> <kikokikona x="222.0" y="295.0" heleuma kikokikona="waena" font-size="10" hoʻopiha="kala kala" opacity="0.8"><puna x="222.0" dy="0">TB-500</tspan></kikokikona> <pololei x="259.0" y="147.5" laula="13.3" kiekie="129.5" hoʻopiha="#f97316" /> <kikokikona x="265.7" y="143.5" heleuma kikokikona="waena" font-size="9" hoʻopiha="kala kala">7</kikokikona> <pololei x="274.3" y="184.5" laula="13.3" kiekie="92.5" hoʻopiha="#38bdf8" /> <kikokikona x="281.0" y="180.5" heleuma kikokikona="waena" font-size="9" hoʻopiha="kala kala">5</kikokikona> <pololei x="289.7" y="240.0" laula="13.3" kiekie="37.0" hoʻopiha="#a78bfa" /> <kikokikona x="296.3" y="236.0" heleuma kikokikona="waena" font-size="9" hoʻopiha="kala kala">2</kikokikona> <kikokikona x="282.0" y="295.0" heleuma kikokikona="waena" font-size="10" hoʻopiha="kala kala" opacity="0.8"><puna x="282.0" dy="0">c-HUAOLELO</tspan></kikokikona> <pololei x="319.0" y="129.0" laula="13.3" kiekie="148.0" hoʻopiha="#f97316" /> <kikokikona x="325.7" y="125.0" heleuma kikokikona="waena" font-size="9" hoʻopiha="kala kala">8</kikokikona> <pololei x="334.3" y="184.5" laula="13.3" kiekie="92.5" hoʻopiha="#38bdf8" /> <kikokikona x="341.0" y="180.5" heleuma kikokikona="waena" font-size="9" hoʻopiha="kala kala">5</kikokikona> <pololei x="349.7" y="258.5" laula="13.3" kiekie="18.5" hoʻopiha="#a78bfa" /> <kikokikona x="356.3" y="254.5" heleuma kikokikona="waena" font-size="9" hoʻopiha="kala kala">1</kikokikona> <kikokikona x="342.0" y="295.0" heleuma kikokikona="waena" font-size="10" hoʻopiha="kala kala" opacity="0.8"><puna x="342.0" dy="0">Mai hoʻolohe</tspan></kikokikona> <pololei x="379.0" y="147.5" laula="13.3" kiekie="129.5" hoʻopiha="#f97316" /> <kikokikona x="385.7" y="143.5" heleuma kikokikona="waena" font-size="9" hoʻopiha="kala kala">7</kikokikona> <pololei x="394.3" y="203.0" laula="13.3" kiekie="74.0" hoʻopiha="#38bdf8" /> <kikokikona x="401.0" y="199.0" heleuma kikokikona="waena" font-size="9" hoʻopiha="kala kala">4</kikokikona> <pololei x="409.7" y="258.5" laula="13.3" kiekie="18.5" hoʻopiha="#a78bfa" /> <kikokikona x="416.3" y="254.5" heleuma kikokikona="waena" font-size="9" hoʻopiha="kala kala">1</kikokikona> <kikokikona x="402.0" y="295.0" heleuma kikokikona="waena" font-size="10" hoʻopiha="kala kala" opacity="0.8"><puna x="402.0" dy="0">Epitalona</tspan></kikokikona> <pololei x="439.0" y="166.0" laula="13.3" kiekie="111.0" hoʻopiha="#f97316" /> <kikokikona x="445.7" y="162.0" heleuma kikokikona="waena" font-size="9" hoʻopiha="kala kala">6</kikokikona> <pololei x="454.3" y="147.5" laula="13.3" kiekie="129.5" hoʻopiha="#38bdf8" /> <kikokikona x="461.0" y="143.5" heleuma kikokikona="waena" font-size="9" hoʻopiha="kala kala">7</kikokikona> <pololei x="469.7" y="258.5" laula="13.3" kiekie="18.5" hoʻopiha="#a78bfa" /> <kikokikona x="476.3" y="254.5" heleuma kikokikona="waena" font-size="9" hoʻopiha="kala kala">1</kikokikona> <kikokikona x="462.0" y="295.0" heleuma kikokikona="waena" font-size="10" hoʻopiha="kala kala" opacity="0.8"><puna x="462.0" dy="0">Emideltide/DSIP</tspan></kikokikona> <kikokikona x="280.0" y="366" heleuma kikokikona="waena" font-size="10" hoʻopiha="kā mākou(--pakuhi-muted, kala kala)">Puna: McDermott Will & Emery, PCAC hōʻike hou (2026-07-28)</kikokikona> </svg> </huahelu>
Pololei ka moʻolelo kaʻina hana. ʻO ʻApelila 2026 Hoʻolaha ka Federal Register e wehe ana i ka docket i hoʻonohonoho i ka hālāwai 23 a 24 Iulai 2026, hoʻokumu ʻia ka docket FDA-2025-N-6895, a pani ʻia nā manaʻo ma 22 Iulai 2026, me na manao i loaa mai e 9 Ua haawiia o Iulai i ke komite (ka Aperila 2026 Hoʻolaha ka Federal Register e wehe ana i ka palapala, 91 FR 20465). ʻO ka heluhelu paʻa ʻana o nā balota e hōʻike i nā kiʻekiʻe ma lalo nei; ʻaʻole i loaʻa nā minuke kūhelu, no laila ua kapa ʻia lākou e like me ka hōʻike ʻana mai ka hālāwai lehulehu (he heluhelu paʻa i nā balota, McDermott Will & Emery, 2026).
|
mea waiwai |
ʻAe |
ʻAʻole |
E hoole |
Ka hopena |
|---|---|---|---|---|
|
BPC-157 |
8 |
6 |
1 |
Paipai ʻia |
|
KPV |
8 |
6 |
1 |
Paipai ʻia |
|
TB- Peptides koke 500 |
8 |
6 |
1 |
Paipai ʻia |
|
c-HUAOLELO |
7 |
5 |
2 |
Paipai ʻia |
|
Mai hoʻolohe |
8 |
5 |
1 |
Paipai ʻia |
|
Epitalona |
7 |
4 |
1 |
Paipai ʻia |
|
Emideltide (DSIP) |
1 |
ʻAʻole ʻōlelo ʻia |
ʻO ka māhele 8-6-1 ka hopena modal, a ʻo DSIP wale nō ka mea i koho ʻia e ke komite. ʻAʻole kau ka koho balota ma ka papa inoa 503A bulks a ʻae ʻole i ka hui ʻana. ʻO ka wehewehe ʻana a FDA i kāna mau ʻāpana manawa like me ka wehe ʻana mai ka Kāhua 2 hāpai wale i kahi kūlana do-not-compound; ʻaʻole ia he papa inoa, a me Kāwai 1 he kūlana hoʻokō ʻole ma mua o ka ʻae ʻia (ʻO ka wehewehe ʻana o FDA i kāna mau ʻāpana manawa, kēia manawa 2026).
Pehea e hoʻopili hou ʻia ai kahi peptide, a pehea ka lōʻihi o ia hana?
ʻAʻohe palena palena kānāwai, a ke holo nei ka mua i nā makahiki, ʻaʻole mahina. Ma ka waena o ʻOkakopa 2026 ʻaʻohe kānāwai i manaʻo ʻia a hope paha; Pono ka FDA e hoʻoholo inā e ʻae i nā ʻōlelo aʻoaʻo, hoʻopuka i kekahi lula i manaʻo ʻia, lawe manaʻo, a laila hoʻopuka i ka lula hope, a ʻo ka mua kokoke loa he a 2016 manaʻo kānāwai ma 10 hoʻopau ʻia nā mea nui ma 2019 (he loiloi kūlana hope o ʻOkakopa, Holani & Naita, 2026).
ʻO ka 2019 Hōʻike ka lula i manaʻo ʻia i ke ʻano o ka ʻanuʻu. Ua manaʻo e waiho 5 nā mea ma ka papa inoa a ʻaʻole e waiho 26 nā mea ʻē aʻe, e hoʻonohonoho i nā manaʻo 4 Kekemapa 2019, a manaʻo e hoʻokō ʻia kekahi lula hope 30 lā ma hope o ka hoʻolaha ʻana (ka 2019 kānāwai i manaʻo ʻia, 84 FR 46688). ʻO Ianuali 2025 Hoʻohui ka leka hoʻomaopopo kuʻikahi i ke ʻano paʻa: Māhele e kū nei 1 Noho nā mea i loko o ke kulekele a hiki i ka hoʻolaha ʻana o FDA i kahi lula hope e hoʻoholo ai inā e kau ʻia lākou ma ka papa inoa 503A bulks. (ka Ianuali 2025 hoʻolaha kūʻokoʻa, 2025).
ʻŌlelo aʻo: ʻAʻohe palena palena kānāwai e hoʻoponopono i kēia kaʻina. Holo pū ka papa inoa 503A a me 503B ma nā hoʻokolohua kānāwai like ʻole, no laila ʻaʻole ʻōlelo ka holomua ma kekahi e pili ana i kekahi.
Hōʻike ka track 503B i ka ʻokoʻa. ʻO ka hoʻolaha 503B a FDA ma nā peptides GLP-1 i manaʻo ʻia ʻaʻole e hoʻokomo i ka semaglutide, tirzepatide a me ka liraglutide, koi ma ka liʻiliʻi 60 lā no ka manaʻo, a hoʻohana i kahi ʻike pono lapaʻau e kāpae i ka hemahema, ʻoluʻolu a me ke kumukūʻai (ʻO ka hoʻolaha 503B a FDA ma nā peptides GLP-1, 91 FR 23431). ʻO ka 503B bulks-list notice mechanism he leka manaʻo i ukali ʻia e kahi leka hoʻomaopopo, a ke hana nei ke kūlana hemahema ma ke ʻano he ala ʻokoʻa ma mua o ka hoʻopaʻapaʻa pono lapaʻau (ka 503B bulks-list hoʻolaha, 2026).
ʻElima pae, i mea e, kēlā me kēia me ka hoʻopaʻa ʻole ʻana i ka pae aʻe: Mea Hana Hana Peptide
-
balota PCAC (aʻoaʻo wale)
-
Hoʻoholo ʻo FDA i ka ʻae ʻana i ka manaʻo
-
Hoʻopuka ʻia ke kānāwai i manaʻo ʻia
-
Manawa manaʻo (90 nā lā ma ka 2019 mua; mea iki loa 60 nā lā ma ke ala 503B)
-
Ka lula hope, pono 30 mau lā ma hope o ka paʻi ʻia ʻana ma ia mua
He aha ka manaʻo o ka ʻikepili analytical hoʻoholo no kahi peptide, kahua ma ke kahua?
ʻO ka peptide characterization package he hoʻoholo i ka maikaʻi ke hoʻopaʻa ʻia kēlā me kēia helu i kahi ala i kapa ʻia, he kolamu i wehewehe ʻia a me ka lōʻihi hawewe ʻike, a i ka wā i hoʻokumu ʻia ai ka ʻike ma mua o ka hoʻomaʻemaʻe ʻana. I Q2(R2), hāpai ʻia ma Step 4 i Nowemapa 2023, helu i nā ʻano hana pono e hōʻike ʻia a kapa hou i ka "ʻano hōʻoia" ma ke ʻano he "ʻano hana" (I Q2(R2), hāpai ʻia ma Step 4 i Nowemapa 2023, I, 2023).
|
Q2(R2) hiʻona hana |
ʻO ka hoʻāʻo peptide e hoʻomaʻamaʻa iā ia |
|---|---|
|
kikoo / koho |
ʻO ka ʻike Orthogonal: hōʻoia nui me ka paʻa chromatographic |
|
Laulā, me nā palena haʻahaʻa, DL a me QL |
Linearity ma ka laulā hana, me nā palena haumia i hoʻopaʻa ʻia |
|
Ka pololei |
Hoʻihoʻi kūʻē i kahi maʻamau kuhikuhi o ka ʻike i ʻike ʻia |
|
pololei (hiki hou, waena, hana hou) |
Hoʻopili hou i nā injections i nā lā, nā kolamu a me nā mea nānā |
|
ʻO ke kūpaʻa |
Ke koʻikoʻi ʻano hana manaʻo: gradient, mahana wela, lōʻihi nalu |
Pono e lawe ʻia kahi pūʻolo he nui i ka ʻike kumu, ka chromatogram a ʻaʻole wale ke kiʻi maʻemaʻe, he hopena ʻike orthogonal, counterion a me net-peptide maʻiʻo, ʻano wai, endotoxin na USP <85> LAL kahi i hoʻokomo ʻia ai ka mea, a me ka sterility e USP <71>, ʻokoʻa mai ka USP <61> helu microbial. ʻAʻohe USP monograph i ʻike ʻia no BPC-157, KPV, TB-500, c-HUAOLELO, Epitalona, Semax a i ʻole emideltide, no laila pili nā mokuna USP ma ke ʻano he hoʻāʻo ʻana ma mua o nā kikoʻī kikoʻī peptide.
Ki Takeaway: ʻO ka maʻemaʻe i hōʻike ʻia ma ke ʻano he pākēneka ʻāpana pili ʻaʻole ia he ʻike, maʻiʻo, kūpaʻa a i ʻole ka hoʻāʻo ʻana i ke kūpono iā ia iho.
He pūʻolo hoʻolako e heluhelu ana "RP-HPLC, C18 kolamu, wai/acetonitrile gradient, ʻIke UV ma 220 nm, ʻO ka maʻemaʻe 99.2%" me ka chromatogram i hoʻopili ʻia e hiki ke loiloi. He laina heluhelu "HPLC maemae: 99%” ʻaʻole, no ka mea, ʻaʻole hiki ke hana hou a hoʻopaʻapaʻa ʻia.
Pehea e hana ai i ka mea noiʻi, ʻokoʻa ka hoʻomākaukau ʻana i hui ʻia a me ka lāʻau i ʻāpono ʻia i nā hōʻike a me nā palapala?
Nā lāʻau i ʻae ʻia, ʻokoʻa nā mea hoʻomākaukau hoʻohui kānāwai a me nā mea noiʻi ma ke kumu hoʻoponopono a me nā hōʻike. Māhele 216.23(d) pili i nā mea i helu ʻia ma ia hāʻawi; ʻaʻole ia e hoʻokumu i kēlā me kēia lāʻau i hoʻohui ʻia i nele i ka palekana a i ʻole nā hōʻike pono.
|
Mea noiʻi-hoʻohana |
Hoʻomākaukau ʻia ʻo 503A |
Laau peptide i aponoia |
|
|---|---|---|---|
|
Kūlana ʻāpono |
ʻAʻohe |
ʻAʻohe; kau ʻia i ka ʻōlelo kuhikuhi |
NDA a i ʻole BLA |
| Nā hōʻike palekana a me ka pono | Ma muli o ka nīnau noiʻi; ʻaʻohe ʻae lāʻau i hōʻike ʻia | ʻAʻole ʻae ʻia ka FDA premarket; ʻokoʻa nā hōʻike ma ka hoʻomākaukau ʻana a me ka hoʻohana ʻana | Loiloi ʻia no ka hōʻailona ʻae ʻia a me ke ala ʻae kūpono |
|
Ka hōʻoia hana |
ʻO ka hoʻāʻo pae kiʻekiʻe wale nō |
Pono i ke kānāwai ka waiwai nui |
Kaʻina hana i hōʻoia ʻia, nā kikoʻī i ʻāpono ʻia |
|
Lepili |
Noiʻi-hoʻohana wale |
Lepili hoʻohuihui |
Lepili ʻia i ʻae ʻia |
| Nā kuleana ma hope o ka mākeke | Pili i ka hana a me ka mana | Pono nā koi federal a me ka moku'āina; ʻokoʻa nā koi ma ke ala | ʻO ka hōʻike palekana a me ka nānā ʻana |
ʻAʻole hoʻoholo ka manaʻo o ka lepili. He ʻAukake 2026 Ua ʻike ʻia ka leka ʻōlelo aʻo ʻaʻole i hoʻokumu ka lepili noiʻi-hoʻohana-wale a ʻaʻole no ka hoʻohana ʻana i ke kanaka., a kapa ʻia ʻo ia he semaglutide, retatrutide, SS-31, PT-141 a me ka tesamorelin (he Augate 2026 palapala hoolaha, FDA, Ref. 735127). Wehe ʻia mai ka Māhele 2 hoʻokiʻekiʻe i kahi kūlana do-not-compound wale nō, a ʻaʻole hoʻololi ka balota maikaʻi i kekahi o nā kolamu ʻekolu ma luna.
ʻO nā hōʻailona e pono ai ke alakaʻi i kahi polokalamu, a he aha ka hoʻoholo e hoʻoulu ai kēlā me kēia?
Kuhi ʻia kēlā me kēia hōʻailona ma lalo i hoʻokahi hoʻoholo, no laila ʻaʻole ʻoe e hoʻopiʻi hou i ka nīnau like i kēlā me kēia mahina. ʻO ke ala koho ka mua: ʻO ke koho kōmike a i ʻole koho papahele ma Overton ke kumu e heluhelu hou ai i nā mea nui i ʻōlelo ʻia, a hiki i ia manawa ke noho nei ke komisina hana i ka mea hana (ka Senate HELP Committee o Sepatemaba 2026 ka lohe koho, 2026).
|
hōʻailona |
He aha ka manaʻo |
Hoʻoholo ia e hoʻomaka |
|---|---|---|
|
Kōmike Senate a i ʻole koho papahele ma ke koho |
Hoʻoholo ka nīnau alakaʻi |
E hoʻopaʻa hou i nā manaʻo hoʻoponopono i kāu papahana papahana |
|
Hoʻopuka a hoʻihoʻi paha i ke kulekele komo manawaleʻa i waiho ʻia iā OMB ma 14 ʻOkakopa 2026 |
ʻO ka manaʻo hoʻokō, ʻaʻole ʻae ʻia |
E mālama i ke kūlana ʻae mai ka manaʻo o ka papahana |
| Hoʻolaha ʻia o kahi lula 503A i manaʻo ʻia | He manaʻo kūkala me kona manawa manaʻo ponoʻī | E hoʻolālā i nā hiʻohiʻona mai ka hoʻolaha maoli; ʻaʻohe manawa paʻa paʻa |
|
ʻO kahi hoʻoholo hope loa 503B ma nā peptides GLP-1 |
Hoʻokahi papa inoa neʻe, ʻaʻole hana kekahi |
Mai hoʻololi i ka holomua 503B i kahi manaʻo 503A |
| Hoʻolaha kūhelu o kahi hālāwai PCAC hou | ʻO ka loiloi aʻoaʻo hou inā hoʻonohonoho ʻia | E heluhelu i ka papahana a me nā lā i paʻi ʻia ma mua o ka hilinaʻi ʻana i kahi wānana |
Ua waiho ʻia ke kulekele komo manawaleʻa iā OMB ma 14 ʻOkakopa 2026 ʻaʻole i hoʻopuka ʻia, a ʻo ke ala kokoke i ka wā lōʻihi ʻo ia ka manaʻo hoʻokō, ʻAʻole ʻae ʻia ka huahana a hiki ke hoʻihoʻi ʻia me ka ʻole o ka hoʻoponopono ʻana; manaʻo ʻia kahi hālāwai PCAC ʻelua ma mua o ka hopena o Pepeluali 2027 no GHK-Cu, LL-37, Dihexa, Melanotan II a me PEG-MGF (he loiloi kūlana hope o ʻOkakopa, Holani & Naita, 2026).
ʻO ka lula hoʻoholo e paʻa me ka nānā ʻole i ke ʻano o ka hoʻoponopono ʻana o ka loiloi: e mālama i ka ʻikepili kikoʻī ma ke ʻano he hoʻololi wale nō āu e mālama ai, a kūkulu i ka pūʻolo hailona i ka pae kiʻekiʻe i kēia manawa. Inā pono ʻoe e hoʻohālikelike i kāu palapala mea hoʻolako i kēia manawa me kēlā maʻamau, ʻO ka noi ʻana i kahi pūʻolo data kikoʻī a me ka hele ʻana ma ka papa inoa o nā kahua ma luna me kahi loea loea kahi ala e hana ai..
Nīnau pinepine
Hana i ka Iulai 2026 ʻO ke koho komite aʻoaʻo e hoʻolilo i kēia mau peptides i ke kānāwai e hui?
ʻAʻole. Ua ʻōlelo ʻo FDA ʻaʻole pili nā ʻōlelo aʻoaʻo komite i ka ʻoihana, a ʻaʻohe mea i koho ʻia ma ka papa inoa nui o 503A (ʻO ka wehewehe ponoʻī a FDA e pili ana i ka hana ʻana o nā komite aʻoaʻo, kēia manawa 2026). Wehe ʻia mai ka Māhele 2 hoʻokiʻekiʻe i kahi kūlana do-not-compound wale nō.
Pehea ka lōʻihi a hiki i kahi peptide ke helu ʻia?
ʻAʻohe lā palena kānāwai. ʻO ka mua kokoke loa he a 2016 hoʻoholo ʻia ke kānāwai i manaʻo ʻia ma 2019, a me ka 2019 ʻO ke kānāwai i manaʻo ʻia e lawe i kahi manawa manaʻo e pani ana i Dekemaba 4, 2019 a me kahi lā i manaʻo ʻia i manaʻo ʻia ma ka pauku VI (ka 2019 kānāwai i manaʻo ʻia, 84 FR 46688).
He palapala hōʻoia o ka nānā ʻana e like me ka ʻae?
ʻAʻole. ʻO kahi palapala hōʻoia no ka nānā ʻana he kiʻi kiʻi o hoʻokahi ʻāpana kūʻē i nā ʻano i wehewehe ʻia, ʻaʻole ia e hōʻike i ka ʻae ʻia, laikini, palekana a i ʻole ka pono, a i ʻole ka ʻae ʻana no ke kanaka a holoholona paha. E noi i ke ala a me ka chromatogram ma hope o kēlā me kēia kiʻi.
Mālama ʻia ka lepili noiʻi-hoʻohana wale i ka mea hoʻolako?
ʻAʻole ʻo ia iho. He ʻAukake 2026 Ua ʻike ʻia ka leka ʻōlelo aʻo ʻaʻole i hoʻokumu ka lepili noiʻi-hoʻohana-wale i ka manaʻo lāʻau ʻole kahi i hōʻike ʻia ai nā koi o ka pūnaewele a me ke kūʻai ʻana i ka wai bacteriostatic i manaʻo ʻia e hoʻohana kanaka. (he Augate 2026 palapala hoolaha, FDA, Ref. 735127).
Ka hopena
ʻO ka mea hiki iā ʻoe ke hana i ka ʻikepili. E kūkulu i ka pūʻolo hailona i ka pae ʻano, hoʻomau i ka chromatogram a me ka hopena ʻike orthogonal, a paʻa paʻa i ka ʻokoʻa ma waena o ka maʻemaʻe a me ka ʻike i hiki ʻole i kahi poʻomanaʻo maikaʻi ke hoʻopololei iā ia. A laila e nānā i nā hōʻailona ʻelima ma luna a e hoʻoneʻe kēlā me kēia i kahi hoʻoholo ma mua o ke ʻano.
ʻO ka hana aʻe he liʻiliʻi a hikiwawe: e lawe i hoʻokahi pūʻolo hīnaʻi o kēia manawa a nānā iā ia e pili ana i ka papa inoa o ke kahua ma ka ʻāpana kikoʻī. ʻO ka mea a ka loiloi e hana ai ma hope, ʻO ia pūʻolo ka ʻāpana o kāu papahana hiki iā ʻoe ke pale aku.
E pili ana i ka mea hoʻopuka. ʻO MOL Changes kahi hui noiʻi a me ka hoʻomohala peptide e hāʻawi ana i ka hoʻolālā kaʻina hana maʻamau, synthesis a me nā lawelawe hoʻololi, a me ka hana ʻana i nā peptides no ka noiʻi ʻana o ka hale hana a me nā noi kalepa. Loaʻa iā ia kahi hoihoi pāʻoihana i ka lako peptide, no laila e kaupaona i kona kuanaʻike e like me ia. ʻAʻole pili ka alakaʻi i luna i kāna huahana.
